Gilead CEO Defends High Price Of HIV Prevention Drug As Necessary For Research, But Lawmakers Aren’t Buying It

“This treatment was developed as a result of investment made by the American taxpayers,” said House Oversight Committee Chairman Elijah E. Cummings (D-Md.). “The problem is that Gilead, the company that now sells the drug, charges astronomical prices.” Gilead charged $800 a month for the drug when it was introduced in 2004. The drug now costs nearly $2,000 a month.

from Kaiser Health News http://bit.ly/2LP9v6r